Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Zocere licenses neuroprotectant technology for stroke and other brain trauma

March 12, 2014

Janssen Pharmaceutica divulges N-type calcium channel blockers for pain

March 11, 2014

Trophos reports topline data for olesoxime in spinal muscular atrophy

March 11, 2014

AbbVie researchers prepare and test PDE10A inhibitors for CNS disorders

March 11, 2014

FDA accepts intravenous carbamazepine NDA for review

March 11, 2014

Phase IIb/III trial of EPI-743 begins in Leigh syndrome

March 10, 2014

Tamoxifen found to have potential in treating spinal cord injury

March 10, 2014

Japanese approval sought for E Keppra monotherapy for partial-onset seizures

March 7, 2014

Omeros reports additional data from phase IIa trial of OMS-824

March 7, 2014

FDA clears Alcobra's IND for metadoxine extended release

March 7, 2014

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...